Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2024 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39228 MULTIPLAN CORPORATION (Exact Name of Registrant as Specified in Its Charter) Delaware 84-3536151 (State or other ju ...

MultiPlan Corporation (MPLN Q1 2024 Earnings Conference Call May 8, 2024 8:00 AM ET Company Participants Shawna Gasik - Vice President, Investor Relations Travis Dalton - Chief Executive Officer Jim Head - Chief Financial Officer Conference Call Participants Joshua Raskin - Nephron Research LLC Operator Good morning, everyone and welcome to the MultiPlan Corporation First Quarter 2024 Earnings Call. My name is Angela, and I will be coordinating your call today. [Operator Instructions] I would now like to ha ...

2021 2024 'Gross sovings identified. Effective fourth quarter 2022, we modified the methodology for capturing and reporting medical charges processed and potential medical cost sovi reviously reported submissions. We believe this new methodology provides additional insight into our business, increases alignment with our revenue reporting, and will pro accurate portrayal of our portfollo of services as we grow our business through the addition of new claims flows and new service offerings. A full description ...

EXHIBIT 99.1 RELEASE MultiPlan Reports First Quarter 2024 Results – Q1 2024 Revenues of $234.5 million, Net Loss of $539.7 million (including a $519.1 million impairment of goodwill and indefinite-lived intangible assets), and Adjusted EBITDA of $146.8 million – Identified potential medical cost savings of approximately $5.7 billion in Q1 2024, up 3% from Q1 2023 and down 3% from Q4 2023 – Repurchased or repaid $24.4 million of face value of debt, including $21.1 million of 6.0% Senior Convertible PIK Notes ...

MultiPlan Corporation (NYSE:MPLN) Q4 2023 Earnings Conference Call February 29, 2024 8:00 AM ET Company Participants Shawna Gasik - Assistant Vice President of Investor Relations Dale White - President and Chief Executive Officer James Head - Executive Vice President and Chief Financial Officer Travis Dalton - Incoming Chief Executive Officer Conference Call Participants Joshua Raskin - Nephron Research Luismario Higuera - Citigroup Operator Hello everyone and welcome to the MultiPlan Corporation Fourth Qua ...

| --- | --- | |------------------------|-------| | | | | | | | | | | | | | | | | MultiPlan Q4 & FY 2023 | | Disclaimer This presentation includes statements that express our management's opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results and therefore are, or may be deemed to be, "forward-looking statements". These forward-looking statements can generally be identified by the use of forward-looking terminology, including the terms "believ ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (MARK ONE) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 o For the transition period from to Commission file number: 001-39228 MULTIPLAN CORPORATION (Exact Name of Registrant as Specified in Its Charter) (State or other jurisdiction of in ...

MultiPlan Reports Fourth Quarter and Full Year 2023 Results NEW YORK, NY — February 29, 2024 — MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE: MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry, today reported financial results for the fourth quarter and full year ended December 31, 2023. "As we close out 2023, I am very encouraged by the progress we have made toward ou ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended September 30, 2023 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39228 MULTIPLAN CORPORATION (Exact Name of Registrant as Specified in Its Charter) Delaware 84-3536151 (State or othe ...

Third Quarter 2023 Results: • Adjusted EBITDA1 of $152.3 million, and Adjusted EBITDA2 margin of 62.7% During the third quarter, we: • Achieved critical milestones in the execution of our Growth Plan, including: • Launched our price transparency solutions, including PlanOptixTM Search in July and PlanOptixTM Intelligence in October • Signed our first customer to our new B2B healthcare payments service through our partnership with ECHO Health 1 See reconciliation of non-GAAP measures included in Appendix 2Ad ...